Yarrow Bioscience Inc
General ticker "YARW" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $7.2M (TTM average)
Yarrow Bioscience Inc follows the US Stock Market performance with the rate: 13.9%.
Estimated limits based on current volatility of 10.6%: low 13.63$, high 16.85$
Factors to consider:
- Company pays dividends (irregularly): last record date 2026-07-22, amount 20.10$ (Y127.30%)
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [11.29$, 33.39$]
- 2026-12-31 to 2027-12-31 estimated range: [8.32$, 24.20$]
Financial Metrics affecting the YARW estimates:
- Negative: with PPE of -3.1 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: negative Net income
- Negative: negative Operating cash flow
- Negative: -0.35 < Inventory ratio change, % of 0
- Negative: Shareholder equity ratio, % of 92.06 > 81.82
- Negative: negative Industry operating income (median)
- Negative: negative Industry operating cash flow (median)
Short-term YARW quotes
Long-term YARW plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.42MM | $0.50MM | $0.57MM |
| Operating Expenses | $29.68MM | $44.14MM | $30.32MM |
| Operating Income | $-29.26MM | $-43.64MM | $-29.75MM |
| Non-Operating Income | $1.39MM | $3.83MM | $3.02MM |
| R&D Expense | $16.31MM | $30.95MM | $19.24MM |
| Income(Loss) | $-27.87MM | $-39.80MM | $-26.73MM |
| Taxes | $0.00MM | $0.00MM | $0.00MM |
| Net Income(Loss)* | $-28.45MM | $-39.83MM | $-26.48MM |
| Stockholders Equity | $88.73MM | $52.09MM | $27.77MM |
| Assets | $97.69MM | $66.91MM | $30.16MM |
| Operating Cash Flow | $-25.34MM | $-33.97MM | $-33.12MM |
| Capital expenditure | $0.00MM | $0.12MM | $0.00MM |
| Investing Cash Flow | $-57.35MM | $23.36MM | $37.37MM |
| Financing Cash Flow | $82.39MM | $-0.14MM | $-0.14MM |
| Earnings Per Share** | $-138.48 | $-46.77 | $-30.96 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.